Non-alcoholic fatty liver disease phenotype
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (3)
Papers in which this entity is mentioned.
- Towards understandings of serine/arginine-rich splicing factors. (2023)
- Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
- CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. (2019)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| non-alcoholic fatty liver disease | phenotype | 12 | 16 |
| nafld | phenotype | 8 | 18 |
| non-alcoholic steatohepatitis | phenotype | 4 | 4 |
| non-alcoholic fatty liver diseases | phenotype | — | — |